These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 18049333

  • 1. Generation of EBV-specific T cells for adoptive immunotherapy: a novel protocol using formalin-fixed stimulator cells to increase biosafety.
    Hammer MH, Brestrich G, Mittenzweig A, Roemhild A, Zwinger S, Subklewe M, Beier C, Kurtz A, Babel N, Volk HD, Reinke P.
    J Immunother; 2007; 30(8):817-24. PubMed ID: 18049333
    [Abstract] [Full Text] [Related]

  • 2. Generation of trispecific cytotoxic T cells recognizing cytomegalovirus, adenovirus, and Epstein-Barr virus: an approach for adoptive immunotherapy of multiple pathogens.
    Karlsson H, Brewin J, Kinnon C, Veys P, Amrolia PJ.
    J Immunother; 2007; 30(5):544-56. PubMed ID: 17589295
    [Abstract] [Full Text] [Related]

  • 3. T cell repertoire and Epstein-Barr virus-specific T cell response in chronic active Epstein-Barr virus infection: a case study.
    Gallot G, Hamidou MA, Clémenceau B, Gaschet J, Tiberghien P, Ferrand C, Vivien R, Barbarot S, Coste-Burel M, Moreau A, Vié H.
    Clin Immunol; 2006 Apr; 119(1):79-86. PubMed ID: 16386957
    [Abstract] [Full Text] [Related]

  • 4. Functional CD4(+) and CD8(+) T-cell responses induced by autologous mitomycin C treated Epstein-Barr virus transformed lymphoblastoid cell lines.
    Meij P, Bloemena E, Palmen N, Brink A, Vervoort MB, Meijer CJ, Middeldorp JM.
    Cell Immunol; 2001 Feb 25; 208(1):25-33. PubMed ID: 11277616
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Isolation and expansion of human adenovirus-specific CD4+ and CD8+ T cells according to IFN-gamma secretion for adjuvant immunotherapy.
    Feuchtinger T, Lang P, Hamprecht K, Schumm M, Greil J, Jahn G, Niethammer D, Einsele H.
    Exp Hematol; 2004 Mar 25; 32(3):282-9. PubMed ID: 15003314
    [Abstract] [Full Text] [Related]

  • 7. Clinical grade generation of hexon-specific T cells for adoptive T-cell transfer as a treatment of adenovirus infection after allogeneic stem cell transplantation.
    Feuchtinger T, Richard C, Joachim S, Scheible MH, Schumm M, Hamprecht K, Martin D, Jahn G, Handgretinger R, Lang P.
    J Immunother; 2008 Mar 25; 31(2):199-206. PubMed ID: 18481389
    [Abstract] [Full Text] [Related]

  • 8. Sustained CD8+ T-cell immune response to a novel immunodominant HLA-B*0702-associated epitope derived from an Epstein-Barr virus helicase-primase-associated protein.
    Turcanová V, Höllsberg P.
    J Med Virol; 2004 Apr 25; 72(4):635-45. PubMed ID: 14981767
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P, Pedrazzoli P, Maccario R, Basso S, Carminati O, Labirio M, Schiavo R, Secondino S, Frasson C, Perotti C, Moroni M, Locatelli F, Siena S.
    J Clin Oncol; 2005 Dec 10; 23(35):8942-9. PubMed ID: 16204009
    [Abstract] [Full Text] [Related]

  • 12. Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
    Subklewe M, Sebelin K, Block A, Meier A, Roukens A, Paludan C, Fonteneau JF, Steinman RM, Münz C.
    Hum Immunol; 2005 Sep 10; 66(9):938-49. PubMed ID: 16360833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HLA type-independent generation of antigen-specific T cells for adoptive immunotherapy.
    Hammer MH, Meyer S, Brestrich G, Moosmann A, Kern F, Tesfa L, Babel N, Mittenzweig A, Rooney CM, Hammerschmidt W, Volk HD, Reinke P.
    Eur J Immunol; 2005 Jul 10; 35(7):2250-8. PubMed ID: 15915543
    [Abstract] [Full Text] [Related]

  • 15. Purification of melanoma reactive T cell by using a monocyte-based solid phase T-cell selection system for adoptive therapy.
    Li J, Mookerjee B, Wagner J.
    J Immunother; 2008 Jan 10; 31(1):81-8. PubMed ID: 18157015
    [Abstract] [Full Text] [Related]

  • 16. Dendritic cells improve the generation of Epstein-Barr virus-specific cytotoxic T lymphocytes for the treatment of posttransplantation lymphoma.
    Wheatley GH, McKinnon KP, Iacobucci M, Mahon S, Gelber C, Lyerly HK.
    Surgery; 1998 Aug 10; 124(2):171-6. PubMed ID: 9706135
    [Abstract] [Full Text] [Related]

  • 17. Establishment and characterization of Epstein-Barr virus-specific human CD4+ T lymphocyte clones.
    Honda S, Takasaki T, Okuno K, Yasutomi M, Kurane I.
    Acta Virol; 1998 Nov 10; 42(5):307-13. PubMed ID: 10358731
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Ex vivo generation of cytotoxic T lymphocytes specific for one or two distinct viruses for the prophylaxis of patients receiving an allogeneic bone marrow transplant.
    Regn S, Raffegerst S, Chen X, Schendel D, Kolb HJ, Roskrow M.
    Bone Marrow Transplant; 2001 Jan 10; 27(1):53-64. PubMed ID: 11244438
    [Abstract] [Full Text] [Related]

  • 20. A sealed and unbreached system for purification, stimulation, and expansion of cytomegalovirus-specific human CD4 and CD8 T lymphocytes.
    Li Pira G, Bottone L, Ivaldi F, Pelizzoli R, Risso M, Tripodi G, Manca F.
    Transfusion; 2006 Dec 10; 46(12):2053-62. PubMed ID: 17176316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.